echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Hepatobiliary Surg Nutr: Gene mutation characteristics of Chinese liver cancer patients!

    Hepatobiliary Surg Nutr: Gene mutation characteristics of Chinese liver cancer patients!

    • Last Update: 2021-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the fourth most common cause of cancer-related death.


    This study aims to analyze the genetic characteristics of HCC patients in China.


    A total of 165 HCC patients were recruited, including 146 men and 19 women.


    Mutation map

    Mutation map

    A total of 1,004 genetic variants were detected in 258 genes in 168 HCC tissues.


    The most common mutant genes are TP53, TERT, CTNNB1, AXIN1, RB1, TSC2, CCND1, ARID1A, and FGF19

    Compared to wild type patients, patients carrying mutations in TP53 Edmondson III-IV stage and a micro- vessel ratio infiltration significantly higher (p <0.


    In stage Edmondson III-IV and micro patients carrying mutations in TP53 vessel ratio significantly higher infiltration vessel in the patient TERT mutations, tumor invasion of the liver capsule proportion was significantly higher in patients with mutations in CTNNB1, Edmondson III level, The proportion of alpha-fetoprotein (AFP) <25 μmg/L and no history of hepatitis B is significantly increased.


    TP53 mutation is independently associated with microvascular invasion and Edmondson grade III-IV TERT mutation is independently associated with liver capsule tumor invasion CTNNB1 mutation is independently associated with AFP

    In summary, the most common mutated genes in Chinese HCC patients are TP53, TERT and CTNNB1.


    The most common mutated genes in Chinese HCC patients are TP53, TERT and CTNNB1.


    Original source:

    Wang Shuo,Shi Huasheng,Liu Tao et al.


    org/10.
    21037/hbsn.
    2019.
    09.
    17" target="_blank" rel="noopener">Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.